Lexaria Bioscience Corp (LXX.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 08/31
| 08-2017 | 05-2017 | 02-2017 | 11-2016 | 08-2016 | |
| Sales | 13 | 29 | 13 | 9 | 9 |
| Cost of Goods | 5 | 9 | 15 | 1 | 3 |
| Gross Profit | 8 | 20 | -2 | 8 | 6 |
| Operating Expenses | 680 | 356 | 455 | 404 | 319 |
| Operating Income | -672 | -336 | -457 | -396 | -313 |
| Interest Expense | 1 | 2 | 2 | 1 | 1 |
| Other Income | -46 | -7 | -6 | -3 | -12 |
| Pre-tax Income | -720 | -344 | -465 | -401 | -327 |
| Net Income Continuous | -720 | -344 | -465 | -401 | -327 |
| Minority Interests | 33 | 5 | 17 | 5 | 12 |
| Net Income | $-687 | $-339 | $-448 | $-395 | $-314 |
| EPS Basic Total Ops | -0.30 | -0.30 | -0.30 | -0.30 | -0.30 |
| EPS Basic Continuous Ops | -0.30 | -0.30 | -0.30 | -0.30 | -0.27 |
| EPS Diluted Total Ops | -0.30 | -0.30 | -0.30 | -0.30 | -0.30 |
| EPS Diluted Continuous Ops | -0.30 | -0.30 | -0.30 | -0.30 | -0.27 |
| EBITDA(a) | $-718 | $-342 | $-463 | $-399 | $-325 |